Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.
- NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_assertion description "[Sorafenib (SOR), a vascular endothelial growth factor receptor (VEGFR) inhibitor, is in wide clinical use for the treatment and prevention of liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.
- NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_assertion evidence source_evidence_literature NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.
- NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_assertion SIO_000772 25176394 NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.
- NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_assertion wasDerivedFrom befree-2016 NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.
- NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_assertion wasGeneratedBy ECO_0000203 NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1215799.RAP0nr-PphEtAGcTx6VETjye8j04idyZWNvJN97wCYYtU130_provenance.